Abstract
Cystic fibrosis (cf) is the most frequent occurring hereditary lethal disease in Western countries. Improvement of treatment strategies in cf have resulted in major improvements of life expectancy. Several decades ago cf was treated exclusively by paediatricians, nowadays the median life expectancy is between 30 and 35 years. Many patients are treated by pulmonologists and other medical specialists for adults. The improved survival has led to the emergence of new complications of the disease, like allergic bronchopulmonary aspergillosis (abpa), cf-related liver diseases, cf-related diabetes mellitus, and osteoporosis. Additionally, patients wish to become parents themselves. Each of these aspects ask attention of both paediatricians (information and prevention) and medical specialists for adults (treatment). Intensive collaboration between these specialists in cf centers and structured transition of care is of urgent importance.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
